Targeted Oncology: FDA Accepts NDA for 18F-FET PET Imaging Agent in Glioma Management
FierceBiotech: Whole-Body Molecular Imaging’s Impact on Understanding Tumor Response and Advancing Immuno-Oncology (IO) Drug Development
What work are you leading in whole-body molecular imaging to help advance immuno-oncology drug development? One facet of my role in scientific partnering and strategy is working with molecular imaging ...
Whole-Body Molecular Imaging’s Impact on Understanding Tumor Response and Advancing Immuno-Oncology (IO) Drug Development
ascopubs.org: Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor–Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and ...
Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...
Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor–Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and ...
ascopubs.org: Phase 2 multicenter clinical trial to evaluate the safety and efficacy of abenacianine for injection (VGT-309), a tumor-targeted, intraoperative molecular imaging agent, for ...
Phase 2 multicenter clinical trial to evaluate the safety and efficacy of abenacianine for injection (VGT-309), a tumor-targeted, intraoperative molecular imaging agent, for ...
MedPage Today: Molecular Imaging Boosted Cancer Detection in Women With Dense Breasts
The need to improve the detection of breast cancer in women with dense breasts has resulted in the use of additional imaging modalities to supplement screening. Supplemental molecular breast imaging ...
News Medical: New molecular imaging agent shows high accuracy in detecting liver cancer
Our study concentrated on imaging glypican-3 (GPC3), a cell surface receptor that is overexpressed in most hepatocellular carcinomas and represents a highly specific target for molecular diagnostics ...